Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBOSTON SCIENTIFIC CORP

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

BOSTON SCIENTIFIC CORP

$41.67Close · Oct 8, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q2 ’2620172018201920202021202220232024202502B4BLatest period Q2 '26. Revenue 5.44B. Gross profit 3.85B. Net profit 905M.
RevenueGross profitNet profit
See which business lines, products, or regions generate the company’s sales.Formula: Company revenue = Σ(segment revenues) + reconciliation adjustments
Q2 ’2620172018201920202021202220232024202501B2B3B4B5BLatest period Q2 '26. Cardiac Rhythm Management 585M. Global Endoscopy Endo Reporting Unit 793M. Global Neuromodulation Nm Reporting Unit 341M. Global Urologyand Pelvic Health Reporting Unit 684M. Electrophysiology EP 916M. Interventional Cardiology Therapies 1.33B. Watchman 507M. Interventional Oncology And Embolization 283M.
Cardiac Rhythm ManagementElectrophysiologyEndoscopyInterventional CardiologyNeuromodulationPeripheral InterventionsUrologyand Pelvic HealthGlobal Crm Reporting UnitGlobal Electrophysiology Ep Reporting UnitGlobal Endoscopy Endo Reporting UnitGlobal Interventional Cardiology Ic Reporting UnitGlobal Neuromodulation Nm Reporting UnitGlobal Peripheral Interventions Pi Reporting UnitGlobal Urologyand Pelvic Health Reporting UnitSpecialty PharmaceuticalsElectrophysiology EPInterventional Cardiology TherapiesWatchmanInterventional Oncology And Embolization
See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
Q2 ’262017201820192020202120222023202420250%50%100%Latest period Q2 '26. Gross margin 70.7%. Operating margin 21.6%. Net profit margin 16.6%.
Gross marginOperating marginNet profit margin
See the amounts the company has committed to pay that its balance sheet does not record yet: leases it has signed that have not started, unconditional purchase and other contractual commitments, and the most it could have to pay under guarantees and credit backstops. Amounts are as the filing reports them at each balance-sheet date.Formula: Commitments = leases not yet commenced + purchase & other commitments + maximum guarantee exposure
Q4 ’252017201820192020202120222023202420250500M1B1.5B2B
      Latest period Q4 '25. Purchase & other commitments 1.8B.
      Leases not yet commencedPurchase & other commitmentsGuarantees & contingent commitments
      Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
      $
      Q2 ’262017201820192020202120222023202420250500M1B
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        Latest period Q2 '26. Operating cash flow 1.5B. Capex -195M. Free cash flow 1.3B.
        Operating cash flowCapexFree cash flow
        Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
        202620172018201920202021202220232024202502B4B6B8B10B12B
            Latest period 2026. Cash 539M. Debt 12.6B.
            CashDebtNet cash
            Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
            $/shareUsing split history cached 2026-10-08; assuming no new splits
            Q2 ’26201720182019202020212022202320242025-1.000.001.002.003.004.00
              • Earnings period 2017-01-01 to 2017-03-31. Shares as of 2017-03-31: 1,369,082,488 source shares.
              • Earnings period 2017-04-01 to 2017-06-30. Shares as of 2017-06-30: 1,370,464,555 source shares.
              • Earnings period 2017-07-01 to 2017-09-30. Shares as of 2017-09-30: 1,372,735,769 source shares.
              • Earnings period 2017-01-01 to 2017-12-31. Shares as of 2017-12-31: 1,373,496,628 source shares.
              • Earnings period 2018-01-01 to 2018-03-31. Shares as of 2018-03-31: 1,379,621,739 source shares.
              • Earnings period 2018-04-01 to 2018-06-30. Shares as of 2018-06-30: 1,381,309,982 source shares.
              • Earnings period 2018-07-01 to 2018-09-30. Shares as of 2018-09-30: 1,383,705,013 source shares.
              • Earnings period 2018-01-01 to 2018-12-31. Shares as of 2018-12-31: 1,384,581,760 source shares.
              • Earnings period 2019-01-01 to 2019-03-31. Shares as of 2019-03-31: 1,390,583,103 source shares.
              • Earnings period 2019-04-01 to 2019-06-30. Shares as of 2019-06-30: 1,391,532,660 source shares.
              • Earnings period 2019-07-01 to 2019-09-30. Shares as of 2019-09-30: 1,393,776,239 source shares.
              • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2019-12-31: 1,394,922,641 source shares.
              • Earnings period 2020-01-01 to 2020-03-31. Shares as of 2020-03-31: 1,399,310,972 source shares.
              • Earnings period 2020-04-01 to 2020-06-30. Shares as of 2020-07-31: 1,430,674,668 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2020-07-01 to 2020-09-30. Shares as of 2020-10-30: 1,431,921,459 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2021-01-29: 1,417,165,707 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2021-01-01 to 2021-03-31. Shares as of 2021-04-30: 1,420,910,855 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2021-04-01 to 2021-06-30. Shares as of 2021-07-30: 1,423,852,648 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2021-07-01 to 2021-09-30. Shares as of 2021-10-29: 1,424,992,477 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2022-01-31: 1,426,724,712 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-04-29: 1,429,571,199 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2022-04-01 to 2022-06-30. Shares as of 2022-07-29: 1,431,614,313 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-10-31: 1,432,311,282 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2023-01-31: 1,434,780,104 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-04-28: 1,437,698,101 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-07-31: 1,464,223,263 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-10-31: 1,464,982,777 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2024-01-31: 1,467,095,627 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-04-29: 1,470,179,843 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-07-30: 1,472,626,135 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-10-29: 1,473,827,485 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2025-01-31: 1,475,778,104 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-04-29: 1,479,446,345 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-07-29: 1,481,751,634 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-10-30: 1,482,442,039 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2026-01-30: 1,483,885,456 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-04-29: 1,486,355,179 source shares. Uses later-dated shares from the same quarterly filing.
              • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-07-30: 1,449,229,526 source shares. Uses later-dated shares from the same quarterly filing.
              Latest period Q2 2026. EPS (TTM) 2.54.
              EPS (TTM)
              How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
              Using split history cached 2026-10-08; assuming no new splits
              Q2 ’26201720182019202020212022202320242025-400x-200x0x200x
                • Earnings period 2017-01-01 to 2017-03-31. Shares as of 2017-03-31: 1,369,082,488 source shares. Weekly price on 2017-03-31.
                • Earnings period 2017-04-01 to 2017-06-30. Shares as of 2017-06-30: 1,370,464,555 source shares. Weekly price on 2017-06-30.
                • Earnings period 2017-07-01 to 2017-09-30. Shares as of 2017-09-30: 1,372,735,769 source shares. Nearby weekly price on 2017-09-29.
                • Earnings period 2017-01-01 to 2017-12-31. Shares as of 2017-12-31: 1,373,496,628 source shares. Nearby weekly price on 2017-12-29.
                • Earnings period 2018-01-01 to 2018-03-31. Shares as of 2018-03-31: 1,379,621,739 source shares. Nearby weekly price on 2018-03-29.
                • Earnings period 2018-04-01 to 2018-06-30. Shares as of 2018-06-30: 1,381,309,982 source shares. Nearby weekly price on 2018-06-29.
                • Earnings period 2018-07-01 to 2018-09-30. Shares as of 2018-09-30: 1,383,705,013 source shares. Nearby weekly price on 2018-09-28.
                • Earnings period 2018-01-01 to 2018-12-31. Shares as of 2018-12-31: 1,384,581,760 source shares. Nearby weekly price on 2018-12-28.
                • Earnings period 2019-01-01 to 2019-03-31. Shares as of 2019-03-31: 1,390,583,103 source shares. Nearby weekly price on 2019-03-29.
                • Earnings period 2019-04-01 to 2019-06-30. Shares as of 2019-06-30: 1,391,532,660 source shares. Nearby weekly price on 2019-06-28.
                • Earnings period 2019-07-01 to 2019-09-30. Shares as of 2019-09-30: 1,393,776,239 source shares. Nearby weekly price on 2019-09-27.
                • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2019-12-31: 1,394,922,641 source shares. Nearby weekly price on 2020-01-03.
                • Earnings period 2020-01-01 to 2020-03-31. Shares as of 2020-03-31: 1,399,310,972 source shares. Nearby weekly price on 2020-04-03.
                • Earnings period 2020-04-01 to 2020-06-30. Shares as of 2020-07-31: 1,430,674,668 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2020-07-31.
                • Earnings period 2020-07-01 to 2020-09-30. Shares as of 2020-10-30: 1,431,921,459 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2020-10-30.
                • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2021-01-29: 1,417,165,707 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2021-01-29.
                • Earnings period 2021-01-01 to 2021-03-31. Shares as of 2021-04-30: 1,420,910,855 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2021-04-30.
                • Earnings period 2021-04-01 to 2021-06-30. Shares as of 2021-07-30: 1,423,852,648 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2021-07-30.
                • Earnings period 2021-07-01 to 2021-09-30. Shares as of 2021-10-29: 1,424,992,477 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2021-10-29.
                • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2022-01-31: 1,426,724,712 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2022-01-28.
                • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-04-29: 1,429,571,199 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2022-04-29.
                • Earnings period 2022-04-01 to 2022-06-30. Shares as of 2022-07-29: 1,431,614,313 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2022-07-29.
                • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-10-31: 1,432,311,282 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2022-10-28.
                • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2023-01-31: 1,434,780,104 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2023-02-03.
                • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-04-28: 1,437,698,101 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2023-04-28.
                • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-07-31: 1,464,223,263 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2023-07-28.
                • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-10-31: 1,464,982,777 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2023-11-03.
                • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2024-01-31: 1,467,095,627 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2024-02-02.
                • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-04-29: 1,470,179,843 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2024-04-26.
                • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-07-30: 1,472,626,135 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2024-08-02.
                • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-10-29: 1,473,827,485 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2024-11-01.
                • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2025-01-31: 1,475,778,104 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2025-01-31.
                • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-04-29: 1,479,446,345 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2025-05-02.
                • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-07-29: 1,481,751,634 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2025-08-01.
                • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-10-30: 1,482,442,039 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2025-10-31.
                • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2026-01-30: 1,483,885,456 source shares. Uses later-dated shares from the same quarterly filing. Weekly price on 2026-01-30.
                • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-04-29: 1,486,355,179 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2026-05-01.
                • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-07-30: 1,449,229,526 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2026-07-31.
                Latest period Q2 2026. P/E ratio 18.4x.
                P/E ratio
                See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
                Stock split history may be out of date.
                20262017201820192020202120222023202420250500M1B1.5B
                    Latest period Shares as of 2026-07-30 (quarter ended 2026-06-30). Shares outstanding 1.4B. Class detail unavailable 1.4B.
                    Class detail unavailable